您的位置: 首页 > 农业专利 > 详情页

COMPOSITIONS DE VACCINS A BASE DE NEO-EPITOPES ET LEURS METHODES D'UTILISATION
专利权人:
ETUBICS CORPORATION;NANTCELL, INC.;NANT HOLDINGS IP, LLC
发明人:
JONES, FRANK R.,RICE, ADRIAN,SOON-SHIONG, PATRICK,NIAZI, KAYVAN,RABIZADEH, SHAHROOZ
申请号:
CA3025648
公开号:
CA3025648A1
申请日:
2017.05.26
申请国别(地区):
CA
年份:
2017
代理人:
摘要:
In certain embodiments, methods and compositions are provided for generating immune responses against tumor neo-antigens or neo-epitopes. In particular embodiments there may be provided methods for constructing and producing recombinant adenovirus-based vector vaccines containing nucleic acid sequences encoding tumor neo-antigens and neo-epitopes that allow for vaccinations in individuals with preexisting immunity to adenovirus. In additional embodiments, methods and compositions are provided for the treatment of cancer using immunotherapy based on recombinant adenovirus-based vectors combined with engineered natural killer cells. In some embodiments, the methods and compositions further comprises a nucleic acid encoding for an immunological fusion partner.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充